These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 286638)

  • 1. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
    Leong SS; Sokal JE; Gomez GA; Horoszewicz JS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C; Miura Y
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of normal CFU-C/suppressor activity in population of alloantigen-stimulated T cells from patients with chronic myelogenous leukemia.
    Maekawa T; Sonoda Y; Yokota S; Abe T
    Exp Hematol; 1986 May; 14(4):316-23. PubMed ID: 2938981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of S-phase-specific agents on granulocyte-macrophage and erythroid progenitor cells obtained from normal individuals and from patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C
    Cancer Res; 1983 Aug; 43(8):3927-31. PubMed ID: 6574819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies.
    Rao SG; Kothari V; Nadkarni K; Ahuja H; Advani S
    Nouv Rev Fr Hematol (1978); 1987; 29(4):231-6. PubMed ID: 3501108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal regulation of granulopoiesis by bone marrow fibroblasts in leukemia.
    Shimizu M; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1987 May; 12(2):67-72. PubMed ID: 3482486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferative activity of granulocyte progenitors from the bone marrow of patients with chronic myeloid leukemia in 14-day culture in vivo].
    Hansz J; Kozłowska-Skrzypczak M
    Acta Haematol Pol; 1989; 20(1):29-35. PubMed ID: 2618564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML).
    Eaves AC; Eaves CJ
    Exp Hematol; 1979; 7 Suppl 5():65-75. PubMed ID: 299448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Range and clinical significance of the number of myeloid-committed stem cells in the blood of patients with acute leukaemia in remission.
    Hinterberger W; Bettelheim P; Höcker P; Lechner K; Neumann E; Niessner H
    Scand J Haematol; 1984 Sep; 33(3):244-51. PubMed ID: 6505626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
    Richman CM; Slapak CA; Toh B
    J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU).
    Allieri MA; Douay L; Deloux J; Smadja N; Najman A; Gorin NC
    Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New developments in understanding the compensatory hematological reactions and their outcomes in local fractionated therapeutic gamma irradiation].
    Danilova MA; Kolesnikova AI; Pavlov VV; Bogatyreva TI; Konopliannikov AG; Lepekhina LA; Kal'sina SSh; Deniskina EF
    Ter Arkh; 1997; 69(7):42-6. PubMed ID: 9424757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of granulocyte-committed progenitors from patients with chronic myeloid leukemia to humoral regulators release by macrophages in agar diffusion chamber culture.
    Hansz J; Sawiński K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):415-23. PubMed ID: 2414171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.